← Back to Search

Dietary Supplement

Tube Feeds for Enteral Feeding Intolerance

N/A
Recruiting
Led By Manpreet S Mundi, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week, 4-6 weeks
Awards & highlights

Study Summary

This trial will enroll patients who require long-term enteral nutrition support, and will compare the use of standard polymeric formulas versus blenderized whole foods. Tolerance will be assessed via questionnaire, and microbiome diversity will be measured via stool samples.

Who is the study for?
This trial is for adults needing tube feeding for at least 4-6 weeks and not eating much by mouth. It's not for those who've had recent probiotics, antibiotics, GI surgery, or certain diseases like diabetes or cancer with low white blood cells. People with allergies to the feeds used in the study can't join either.Check my eligibility
What is being tested?
The study compares two types of tube feeding: blenderized whole foods versus standard formula. Participants will answer questions about how well they tolerate their feeds and provide stool samples to see if one type leads to a healthier gut microbiome.See study design
What are the potential side effects?
Possible side effects may include digestive discomfort such as bloating, gas, constipation or diarrhea due to different food compositions in the tube feeds.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week, 4-6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 week, 4-6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of goal calories provided
Secondary outcome measures
Gut microbiome

Trial Design

2Treatment groups
Active Control
Group I: Polymeric Tube FeedsActive Control1 Intervention
This arm will be receiving Polymeric Tube Feeds as a part of the regular HEN Protocol.
Group II: Blenderized Tube FeedsActive Control1 Intervention
This arm will be receiving Blenderized tube feeds as a part of the regular HEN Protocol.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,233 Previous Clinical Trials
3,771,776 Total Patients Enrolled
Manpreet S Mundi, MDPrincipal InvestigatorMayo Clinic
2 Previous Clinical Trials
42 Total Patients Enrolled

Media Library

Blenderized Tube Feeds (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT03795870 — N/A
Enteral Feeding Intolerance Clinical Trial 2023: Blenderized Tube Feeds Highlights & Side Effects. Trial Name: NCT03795870 — N/A
Blenderized Tube Feeds (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03795870 — N/A
Enteral Feeding Intolerance Research Study Groups: Polymeric Tube Feeds, Blenderized Tube Feeds

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the scope of recruitment for this trial?

"Affirmative. According to information found on the clinicaltrials.gov website, this trial is currently recruiting new participants; it was first posted in November 2019 and last updated in April 2022. The research team hopes to enrol 50 patients from one site alone."

Answered by AI

Is this research initiative currently seeking participants?

"Data hosted on clinicaltrials.gov suggests that this trial is still open to participants; it was posted in November 2019 and the information has been recently refreshed as of April 2022."

Answered by AI
~4 spots leftby Dec 2024